Eisai
4523.T
#2079
Rank
C$13.18 B
Marketcap
C$46.73
Share price
6.09%
Change (1 day)
12.72%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.21. In 2026 the company made an earnings per share (EPS) of C$1.21 a decrease over its 2025 EPS that were of C$1.53.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.21-21.04%
2025C$1.5311.85%
2024C$1.37-32.63%
2023C$2.035.52%
2022C$1.92-74.01%
2021C$7.39-66.58%
2020C$22.1298.24%
2019C$11.1617.01%
2018C$9.5437.78%
2017C$6.92-27.62%
2016C$9.5635.33%
2015C$7.07-2.82%
2014C$7.27-27.66%
2013C$10.05-27.49%
2012C$13.87-12.67%
2011C$15.8888.08%
2010C$8.44-11.06%
2009C$9.49-390.15%
2008C-$3.27-127.78%
2007C$11.78347.11%
2006C$2.634.38%
2005C$2.527.4%
2004C$2.3543.03%
2003C$1.6425.09%
2002C$1.3152.67%
2001C$0.8669.76%
2000C$0.51